Home Compare FME.DE
Peer Analysis

Fresenius Medical Care AG — Peer Companies & Stock Comparisons

Fresenius Medical Care AG's functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.

Compare FME.DE with peers
Comparison FME.DE peer score
Fresenius Medical Care AG vs Fresenius SE & Co. KGaA
62 Compare →
Fresenius Medical Care AG vs IQVIA Holdings Inc.
57 Compare →
Fresenius Medical Care AG vs Align Technology, Inc.
59 Compare →
Fresenius Medical Care AG vs GE HealthCare Technologies Inc.
54 Compare →
Fresenius Medical Care AG vs Tenet Healthcare Corporation
51 Compare →
Fresenius Medical Care AG vs DaVita Inc.
64 Compare →
Fresenius Medical Care AG vs Koninklijke Philips N.V.
24 Compare →
Fresenius Medical Care AG vs Danone S.A.
42 Compare →
Fresenius Medical Care AG vs Galenica AG
48 Compare →

Full FME.DE analysis in AssetNext

View the complete Fresenius Medical Care AG report including all peer dimensions.

Open in AssetNext →

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.